Our leadership, including the management team and Board of Directors, is made up of venture capital investing,  AI technology, biotechnology and pharmaceutical industry experts who are recognized for their contributions to discovering and developing new therapies and their track record of successfully bringing creating and managing AI-Enabled drug discovery startups.  

Greg Getten

Co-Founder, Chairman

Sehrish Naz, PhD

Co-Founder, Chief Operating Officer

Nabila Berrabia

Co-Founder, Chief Product Officer

Girinath Pillai, PhD

Co-Founder, Technical Advisor

Henok G. Woldu, PhD

Advisor, Data Science

Board Members & Advisors

Daniel Kwong

Board Member

Rick Sayegh, MD, MBA

Board Advisor

Raymond Choo, PhD

Board Advisor

Mario Rossi, PhD

Board Advisor

Pamela Garzone, PhD

Board Advisor

Research Team

Our team of scientist create algorithms to perform tasks which traditionally rely on human intelligence generating data and analysis arrive at safe and efficacious new drugs faster and at lower cost resulting in profound impact in redefining how scientists develop new drugs, tackle disease, and more. Additionally, blockchain technology is applied to several aspects of the drug discovery and development lifecycle, namely data management, clinical trials, intellectual property (IP), royalties and licensing, ensuring drug authenticity and supply chain compliance

Siham Lakrikh, PhD

Researcher, Drug Discovery

Sajda Ashra, PhD

Researcher, Drug Discovery

Victor Adediwura

Researcher, Drug Discovery

Mohit Sharma PhD

Researcher, Drug Discovery

Ghassan Hadj Ahmed

Researcher, Platform Development

Noureddine Boumahdi

Researcher, Platform Development